Hot Pursuit     26-Dec-23
Biocon Ltd soars 1.18%, Gains for third straight session
Biocon Ltd is quoting at Rs 249.2, up 1.18% on the day as on 12:49 IST on the NSE. The stock is down 6.1% in last one year as compared to a 18.18% gain in NIFTY and a 30.28% gain in the Nifty Pharma index.

Biocon Ltd is up for a third straight session in a row. The stock is quoting at Rs 249.2, up 1.18% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.37% on the day, quoting at 21428.9. The Sensex is at 71339.72, up 0.33%. Biocon Ltd has added around 6.91% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has added around 4.02% in last one month and is currently quoting at 16394.35, up 0.88% on the day. The volume in the stock stood at 21.74 lakh shares today, compared to the daily average of 32.46 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 249.85, up 1.17% on the day. Biocon Ltd is down 6.1% in last one year as compared to a 18.18% gain in NIFTY and a 30.28% gain in the Nifty Pharma index.

The PE of the stock is 492.4 based on TTM earnings ending September 23.

Previous News
  Market at day’s high; VIX climbs 3.96%; realty shares advance
 ( Market Commentary - Mid-Session 18-Apr-24   12:37 )
  Biocon
 ( Results - Analysis 13-Nov-23   12:15 )
  Sensex spurts 901 pts; Nifty above 22,400; European mkt opens higher
 ( Market Commentary - Mid-Session 28-Mar-24   13:36 )
  Biocon Biologics completes integration of Viatris' biosimilars business in 31 European countries
 ( Corporate News - 30-Nov-23   16:49 )
  Biocon jumps after inking pact with Biomm SA
 ( Hot Pursuit - 18-Apr-24   11:47 )
  Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
 ( Corporate News - 09-Nov-23   09:15 )
  Biocon Biologics' Malaysian unit enters Malaysia Book of Record
 ( Corporate News - 05-Aug-22   11:14 )
  Biocon Ltd up for third straight session
 ( Hot Pursuit - 02-Feb-24   13:05 )
  Biocon Biologics set to introduce YESAFILI®, a proposed biosimilar to EYLEA® in Canadian market
 ( Corporate News - 04-Mar-24   09:30 )
  Biocon
 ( Results - Analysis 16-Feb-23   10:55 )
  Biocon to announce Quarterly Result
 ( Corporate News - 07-Jan-23   10:06 )
Other Stories
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
  Vipul Organics hits all-time high after board OKs Rs 25 cr right issue
  01-Oct-24   15:06
  Magellanic Cloud Ltd leads losers in 'A' group
  01-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  01-Oct-24   14:45
  GE Power India rises on bagging order worth Rs 240-cr
  01-Oct-24   14:41
  Volumes jump at Caplin Point Laboratories Ltd counter
  01-Oct-24   14:30
  TVS Motor registers 20% growth in September 2024 sales; Q2 total sales at 12.28 lakh units
  01-Oct-24   14:07
  Oil and Gas shares slide
  01-Oct-24   14:00
  Telecom shares fall
  01-Oct-24   14:00
  Real Estate stocks slide
  01-Oct-24   14:00
Back Top